The implications of suboptimal year-1 outcomes with disease-modifying therapy in employees with multiple sclerosis.

Multiple sclerosis (MS) poses a substantial employer burden in medically related absenteeism and disability costs due to the chronic and debilitating nature of the disease.Although previous studies...